Genetic polymorphism of CYP2D6 in the Japanese population

Pharmacogenetics. 1999 Oct;9(5):601-5.

Abstract

The frequencies of CYP2D6 mutations in a Japanese population were investigated. Individuals were classified into three groups: control individuals, cancer patients and Parkinsonians. Genotyping for CYP2D6*3, CYP2D6*4 and CYP2D6*18 was carried out using the polymerase chain reaction, and that for CYP2D6*5 was also carried out using XbaI restriction fragment length polymorphism. The frequencies of the CYP2D6*3, CYP2D6*4, CYP2D6*5 and CYP2D6*18 mutant alleles were 0%, 0.77%, 4.10% and 0.53% in more than 256 Japanese control individuals, respectively. Based on these data, the population frequency of the CYP2D6 poor metabolizer phenotype was estimated to be 0.29%. The distribution of the four mutated alleles was not significantly different between control individuals and cancer patients or Parkinsonians.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Base Sequence
  • Case-Control Studies
  • Cytochrome P-450 CYP2D6 / genetics*
  • Cytochrome P-450 CYP2D6 / metabolism
  • DNA Primers / genetics
  • Gene Frequency
  • Humans
  • Japan
  • Mutation
  • Neoplasms / enzymology
  • Neoplasms / genetics
  • Parkinson Disease / enzymology
  • Parkinson Disease / genetics
  • Pharmacogenetics
  • Phenotype
  • Polymerase Chain Reaction
  • Polymorphism, Genetic*
  • Polymorphism, Restriction Fragment Length

Substances

  • DNA Primers
  • Cytochrome P-450 CYP2D6